Name:
Streptococcus didelphis Rurangirwa et al. 2000
DSM No.:
15616, Type strain dsm-15616 dsm15616 dsm 15616 Streptococcus didelphis
Strain designation:
WADDL 94-11374-1
Other collection no.
or WDCM no.:
ATCC 700828,CCUG 45419
Isolated from:
opposum, Didelphis virginiana, with suppurative dermatitis and hepatic fibrosis
Country:
United States of America
Date of sampling:
before 12.06.2003
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- ATCC <- Washington Animal Dis. Diagn. lab. <- C. A. Teitzel
Summary and
additional information:
<- ATCC <- Washington Animal Dis. Diagn. lab. <- C. A. Teitzel. Opposum, Didelphis virginiana, with suppurative dermatitis and hepatic fibrosis; USA. Type strain. Taxonomy/description (7692). (Medium 92 or 693, 37°C, microaerophilic)
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
